HAL-2/8
General Information
DRACP ID DRACP02011
Peptide Name HAL-2/8
Sequence GKwMSLLKHILK
Sequence Length 12
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
HeLa | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | IC50=15±3 µM | MTT assay | 48 h | 1 |
SW480 | Colon adenocarcinoma | Carcinoma | IC50> 40 µM | MTT assay | 48 h | 1 |
CCRF-CEM | Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia | Leukemia | Not available | MTT assay | 48 h | 1 |
Hemolytic Activity Rat erythrocytes: IC50=99 μM
Normal (non-cancerous) Cytotoxicity HUVEC: IC50=52±3 μM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antimicrobial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification w=D-Trp
Chiral Mix
Physicochemical Information
Formula C58H104N16O12S
Absent amino acids ACDEFNPQRTVWY
Common amino acids KL
Mass 144602
Pl 11.1
Basic residues 4
Acidic residues 0
Hydrophobic residues 4
Net charge 4
Boman Index -174
Hydrophobicity 14.17
Aliphatic Index 130
Half Life
/
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 22100226
Title Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells
Doi 10.1016/j.peptides.2011.11.002
Year 2012
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available